Algernon Pharmaceuticals (AGNPF) announced that its wholly owned subsidiary Algernon NeuroScience, has appointed Netcapital Securities for its ...
“We are pleased that Algernon NeuroScience has selected Netcapital Securities as its broker-dealer to provide critical compliance and operational support for this offering,” said Martin Kay, CEO at ...
A more recent study published in 2023 in the same journal compared the experiences of a person who had both a near-death experience and a trip on 5-MeO-DMT, a powerful psychedelic cousin of DMT ...
Called DMT (N,N-Dimethyltryptamine), the naturally occurring molecule is found in plants, animals and perhaps even the human brain. When consumed recreationally, it produces powerful visual and ...
Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...
Ocrevus treatment was linked to increases in myelin and reductions in iron in MS patients with paramagnetic rim lesions, per ...
In macOS, a Text Clipping is a selection of text that you've dragged from an application to another location on your Mac, where it becomes a unique kind of standalone file. The relatively little ...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...
The church also offers Dimethyltryptamine, also known as DMT, which Dezaval said must be done on-site. “It’s very easy to hear the words ‘Psychedelic Church of Colorado Springs’ and have a ...
Day 2 (April 20): Will focus more on the spirituality side and explore the intersection of psychedelics, spirituality, cannabis, magic mushrooms, DMT, ancient traditions, and modern breakthroughs.
Disease-modifying therapies (DMTs) may help lower the risk of children's bone fractures in spinal muscular atrophy (SMA), a ...
The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and ...